| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 409,070 | 402,384 | 309,528 | | Cost of Revenue | 227,826 | 212,109 | 147,462 | | | Gross Profit | 181,244 | 190,275 | 162,066 | | | Operating Expenses | | Research Development | 25,909 | 23,836 | 19,981 | | Selling General and Administrative | 161,042 | 172,246 | 125,500 | | Non Recurring | 57,456 | 80,152 | 1,974 | | Others | 11,663 | 12,657 | 10,976 | | | | Total Operating Expenses | 256,070 | 288,891 | 158,431 | | | | Operating Income or Loss | (74,826) | (98,616) | 3,635 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (28,296) | (5,032) | 15,617 | | Earnings Before Interest And Taxes | (103,122) | (103,648) | 19,252 | | Interest Expense | 8,981 | 9,086 | 3,038 | | Income Before Tax | (112,103) | (112,734) | 16,214 | | Income Tax Expense | 1,168 | 10,850 | 3,062 | | Minority Interest | 1,364 | 18,551 | (2,312) | | | | Net Income From Continuing Ops | (111,907) | (105,033) | 10,840 | | | Non-recurring Events | | Discontinued Operations | (2,295) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (114,202) | (105,033) | 10,840 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($114,202) | ($105,033) | $10,840 |
|
1.48% Nasdaq 
Income Statement
